Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? Authors' response.

Supady, Alexander; Duerschmied, Daniel

Supady, Alexander; Duerschmied, Daniel.

Supady A; Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center, Faculty of Medicine, University of Freiburg, Germany; Department of Cardiology and Angiology I, Heart Center, University of Freiburg, Germany; Heidelberg Institute of Global Health, University of Heidelberg, Germany. Electronic address: alexander.supady@uniklinik-freiburg.de.
Duerschmied D; Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center, Faculty of Medicine, University of Freiburg, Germany; Department of Cardiology and Angiology I, Heart Center, University of Freiburg, Germany.

J Crit Care ; 66: 31-32, 2021 12.

Article in English | MEDLINE | ID: covidwho-1366562

Subject(s)

COVID-19; Extracorporeal Membrane Oxygenation; Hemoperfusion; Humans; SARS-CoV-2

Keywords

COVID-19; Coronavirus; Cytokines; Extracorporeal membrane oxygenation; Hemoadsorption; Interleukin-6

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Extracorporeal Membrane Oxygenation / Hemoperfusion / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: J Crit Care Journal subject: Critical Care Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google